Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

23
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
23
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

410
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
410
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K
Stimulants01:29

Stimulants

137
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
137
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

134
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
134
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

1.2K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapy.

International journal of biological macromolecules·2026
Same author

Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events.

International journal of biological macromolecules·2026
Same author

A Multiphase CT-Based Integrated Deep Learning Framework for Rectal Cancer Detection, Segmentation, and Staging: Performance Comparison with Radiologist Assessment.

Journal of imaging·2026
Same author

To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization.

NPJ vaccines·2025
Same author

Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacy.

Bioengineering & translational medicine·2025
Same author

Results of phase Ib/II trial of PEP503 (NBTXR3, radioenhancer) with chemoradiotherapy in patients with rectal cancer.

Nanomedicine (London, England)·2025
Same journal

Abuse Potential and Neurotoxic Effects of the Synthetic Cannabinoid 4F-ABUTINACA Self-Administration in Adult Male Rats.

Addiction biology·2026
Same journal

Longitudinal Cognitive Evolution in Alcohol Use Disorder Patients: Role of Inflammation, Time of Abstinence and Apolipoprotein Profile.

Addiction biology·2026
Same journal

The Interplay Between Sleep Disturbance, Glymphatic Dysfunction and Altered Brain Networks in Internet Gaming Disorder: A Multimodal Neuroimaging Study.

Addiction biology·2026
Same journal

Correction to "Learning Mechanisms in Alcohol Use Disorders".

Addiction biology·2026
Same journal

Abnormal Brain Structural Covariance Networks of Cortical Thickness in Cocaine Use Disorder.

Addiction biology·2026
Same journal

The Orexin System Modulates Stress-Induced Alcohol Preference and Reinstatement in Adolescents: Bioinformatics and Experimental Evidence.

Addiction biology·2026
See all related articles

Related Experiment Video

Updated: May 12, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.1K

Reduced Sensitivity to Negative Feedback May Lead to Risky Decision-Making in Amphetamine Users.

Yu-Hua Liu1, Chiao-Yun Chen1, Neil G Muggleton2,3

  • 1Department of Criminology, National Chung Cheng University, Chiayi, Taiwan.

Addiction Biology
|May 5, 2025
PubMed
Summary
This summary is machine-generated.

Amphetamine users exhibit impaired decision-making due to reduced sensitivity to negative feedback. This neural difference may explain their increased tendency for risky behaviors and difficulty learning from mistakes.

Keywords:
Balloon Analogue Risk Task (BART)Behavioural Inhibition System (BIS)ERNFRNamphetaminerisking decision making

More Related Videos

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice
10:28

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice

Published on: February 18, 2016

16.9K
A Conflict Model of Reward-seeking Behavior in Male Rats
06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

7.3K

Related Experiment Videos

Last Updated: May 12, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.1K
Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice
10:28

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice

Published on: February 18, 2016

16.9K
A Conflict Model of Reward-seeking Behavior in Male Rats
06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

7.3K

Area of Science:

  • Neuroscience
  • Psychology
  • Addiction Research

Background:

  • Amphetamine abuse is prevalent in Taiwan, often linked to risky decision-making.
  • The neural underpinnings of this risky behavior in amphetamine users are not well understood.

Purpose of the Study:

  • To investigate the relationship between neural mechanisms and risky decision-making in amphetamine abusers.
  • To explore differences in behavioral control and response to negative feedback.

Main Methods:

  • Utilized the Balloon Analogue Risk Task (BART) to assess risky decision-making.
  • Employed event-related potential (ERP) recordings to measure neural responses.
  • Administered questionnaires on behavioral control, including the Behavioral Inhibition System (BIS) scale.

Main Results:

  • Amphetamine users scored lower on the BIS scale compared to controls.
  • Users showed reduced amplitudes in feedback-related negativity (FRN) and error-related negativity (ERN) ERP components after negative feedback.
  • Amphetamine users demonstrated decreased sensitivity to aversive stimuli.

Conclusions:

  • Amphetamine users may have a reduced capacity to learn from mistakes due to diminished neural responses to negative feedback.
  • This neural characteristic could contribute to a higher propensity for engaging in risky decision-making and repeated drug abuse.